Literature DB >> 1645298

Absence of insulinotropic glucagon-like peptide-I(7-37) receptors on isolated rat liver hepatocytes.

P F Blackmore1, S Mojsov, J H Exton, J F Habener.   

Abstract

The effects of glucagon and the glucagon-like peptide GLP-1(7-37) were compared in rat liver hepatocytes. Glucagon elevated cAMP, elevated intracellular free calcium ([Ca2+]i), activated phosphorylase and stimulated gluconeogenesis, whereas GLP-1(7-37) was without effect on any of these parameters. GLP-1(7-37) did not block any of the actions of glucagon. The glucagon analog, des His1[Glu9] glucagon amide, was a partial agonist in liver, but also was an effective antagonist of glucagon actions in liver but not those of GLP-1(7-37) in islet B cells. It was concluded that in the rat, GLP-1(7-37) is a potent insulin secretagogue [1] but is without effect on liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645298     DOI: 10.1016/0014-5793(91)80541-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.

Authors:  Xiaokun Ding; Neeraj K Saxena; Songbai Lin; Nitika Arora Gupta; Narita Gupta; Frank A Anania
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

2.  Metabolic and endocrine functions of glucagon-like peptides - evolutionary and biochemical perspectives.

Authors:  T P Mommsen; E M Plisetskaya
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

3.  Glucagon-like peptide-1(7-36) amide and glycogen synthesis in the liver.

Authors:  Y Nakagawa; K Kawai; H Suzuki; S Ohashi; K Yamashita
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

4.  Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors.

Authors:  Dominique Dardevet; Mary Courtney Moore; Catherine A DiCostanzo; Ben Farmer; Doss W Neal; Wanda Snead; Margaret Lautz; Alan D Cherrington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-07-28       Impact factor: 4.052

5.  Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis.

Authors:  Eva Tomas; Joel F Habener
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

Review 6.  Glucagon-like peptide-1, a new hormone of the entero-insular axis.

Authors:  C Orskov
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

7.  Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

Authors:  G G Holz; W M Kühtreiber; J F Habener
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

8.  Structure and biological activity of glucagon and glucagon-like peptide from a primitive bony fish, the bowfin (Amia calva).

Authors:  J M Conlon; J H Youson; T P Mommsen
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.